EPL Limited Board Officially Approves Strategic Merger with Indovida India
EPL Limited's board formally approved the strategic merger with Indovida India Private Limited through official regulatory filings, creating a $1 billion revenue packaging entity valued at approximately $2 billion. The merger involves comprehensive agreements including implementation, shareholders', and transition services arrangements, with expected closure within 12 months subject to regulatory approvals.
*this image is generated using AI for illustrative purposes only.
EPL Limited 's board of directors officially approved the comprehensive merger scheme with Indovida India Private Limited on March 29, 2026, through formal regulatory filings under Regulation 30 of SEBI LODR Regulations. The board meeting, held from 5:00 PM to 5:25 PM IST, formalized the creation of a $1 billion revenue entity valued at approximately $2 billion, positioning the combined entity as one of the largest emerging markets packaging platforms.
Official Board Resolutions and Regulatory Framework
The board formally approved the scheme of amalgamation by way of merger by absorption under Sections 230 to 232 of the Companies Act, 2013. The comprehensive approval encompasses multiple strategic agreements essential for the merger's implementation:
| Agreement Type: | Parties Involved | Purpose |
|---|---|---|
| Merger Implementation Agreement (MIA): | EPL, Indovida India, Indorama Netherlands B.V. | Transaction execution framework |
| Shareholders' Agreement (SHA): | EPL, Epsilon Bidco Pte. Ltd., Indorama Netherlands B.V. | Post-merger governance structure |
| Transition Services Agreement (TSA): | EPL, Indorama Ventures Global Services, Indorama Netherlands B.V. | 5-10 year support services |
Transaction Valuation and Share Exchange Structure
The merger establishes significant value creation with EPL being valued at approximately $1.20 billion, representing INR 339 per share - a 70% premium to Friday's closing price. The share exchange ratio has been determined at 286 fully paid-up equity shares of EPL (face value ₹2 each) for every 10,000 fully paid-up equity shares of Indovida India (face value ₹10 each):
| Valuation Metrics: | EPL Limited | Indovida India | Combined Entity |
|---|---|---|---|
| Valuation: | ~$1.20 billion | ~$0.70 billion | ~$2.00 billion |
| Revenue: | INR 4,568 crores | INR 3,809 crores | ~$1.00 billion |
| Premium/Discount: | 70% premium | 35% discount | - |
Financial Scale and Performance Integration
The merger combines substantial packaging companies with significant consolidated scale. Based on December 31, 2025 financial metrics, the transaction demonstrates substantial magnitude:
| Company: | Turnover (₹ Crores) | Net-worth (₹ Crores) | EBITDA (₹ Crores) | EBITDA Margin |
|---|---|---|---|---|
| EPL Limited: | 4,568.00 | 1,717.00 | 930.00 | 20.40% |
| Indovida India: | 3,809.00 | 6,459.00 | 810.00 | 21.30% |
| Combined Entity: | 8,377.00 | 8,176.00 | 1,750.00 | 20.90% |
The merger is expected to be margin accretive, with 2025 EBIT margin expanding from 12.40% for EPL to 13.60% for the merged entity, while RoCE is projected to increase from 18.70% to 20.90%.
Shareholding Structure Transformation
The merger will significantly alter EPL's shareholding structure, with Indorama Ventures emerging as co-promoter holding 51.80% ownership and Blackstone maintaining 16.60% stake:
Pre-Merger Shareholding (March 29, 2026):
| Category: | No. of Shares | Percentage |
|---|---|---|
| Promoter/Promoter Group: | 8,44,79,781 | 25.97% |
| Public: | 24,08,29,927 | 74.03% |
| Total: | 32,53,09,708 | 100.00% |
Post-Merger Shareholding (Projected):
| Category: | No. of Shares | Percentage |
|---|---|---|
| Promoter/Promoter Group: | 34,87,01,552 | 68.37% |
| Public: | 16,13,35,842 | 31.63% |
| Total: | 51,00,37,394 | 100.00% |
Regulatory Approvals and Implementation Timeline
The merger requires comprehensive regulatory approvals including NCLT, SEBI, stock exchanges, CCI, and requisite shareholder majorities. The transaction involves multiple jurisdictions with 40 combined manufacturing facilities across 17 countries and approximately 8,700+ employees.
| Service Agreement Details: | Specifications |
|---|---|
| TSA Duration: | 5-10 years post-merger |
| 2026 Service Fees Cap: | USD 2,400,000 total |
| Raw Material Supply: | 7 years at 2025 commercial terms |
| Expected Closure: | Next ~12 months |
Goldman Sachs serves as financial advisor, with Ernst & Young providing fairness opinion on the swap ratio. BDO Valuation Advisory LLP and D and P India Advisory Services issued joint valuation reports supporting the share exchange ratio determination.
Strategic Business Rationale
The merger creates a diversified multi-format packaging platform spanning flexible and rigid packaging solutions. EPL contributes expertise in laminated tubes, extruded tubes, and caps & closures across 21 facilities in 11 countries, while Indovida brings rigid PET packaging capabilities through 19 facilities across 9 countries.
Hemant Bakshi will remain Group CEO of the merged entity, while Sunil Marwah will continue leading Indovida business operations. The combined entity will focus on emerging markets, with approximately 75% of revenue expected from these high-growth regions.
Historical Stock Returns for EPL
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.66% | +1.39% | -7.99% | -6.00% | -3.72% | -8.99% |
How will the combined entity's 75% revenue exposure to emerging markets perform amid potential global economic volatility over the next 12-18 months?
What specific synergies and cost savings targets has the merged entity set to justify the $2 billion valuation, and when are these expected to materialize?
Could regulatory approval delays from NCLT, SEBI, or CCI extend beyond the projected 12-month timeline and impact the merger's financial assumptions?
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
